Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 23062-06-8
2. Fasedienol
3. Aloradine
4. 4,16-androstadien-3-beta-ol
5. 4,16-androstadien-3beta-ol
6. Dtw1nj7ijh
7. (3s,8s,9s,10r,13r,14s)-10,13-dimethyl-2,3,6,7,8,9,10,11,12,13,14,15-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol
8. Androsta-4,16-dien-3-ol, (3b)-
9. (3s,8s,9s,10r,13r,14s)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-ol
10. (3as,3bs,7s,9ar,9bs,11ar)-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,7h,8h,9h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-ol
11. 4-androstadienol
12. Unii-dtw1nj7ijh
13. Fasedienol [inn]
14. Aloradine [who-dd]
15. Ph94b
16. Androsta-4,16-dien-3beta-ol
17. Schembl4075431
18. Androsta-4,16-diene-3beta-ol
19. Dtxsid901032322
20. (3b)-androsta-4,16-dien-3-ol
21. Yaa06206
22. Mfcd00271236
23. Zinc34031047
24. Akos028109412
25. As-60043
26. Androsta-4,16-dien-3-ol, (3.beta.)-
27. Hy-145567
28. Cs-0376082
29. Q20707597
| Molecular Weight | 272.4 g/mol |
|---|---|
| Molecular Formula | C19H28O |
| XLogP3 | 4.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 272.214015512 g/mol |
| Monoisotopic Mass | 272.214015512 g/mol |
| Topological Polar Surface Area | 20.2 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 476 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Intended for the acute treatment of social phobia.
Vomeropherin compounds are directly delivered to the nasal passages using either a metered nasal spray or a metered nasal aerosol. By virtue of the chemoreceptors location in the nasal passages, direct connections to the hypothalamus and limbic system and the ability of our compounds to act locally, vomeropherins do not need to achieve systemic absorption and distribution. This provides a significant therapeutic advantage over traditional therapeutics targeted at the hypothalamus and limbic system that require access to systemic circulation and must cross the blood-brain barrier followed by uptake into the brain to exert effects.
Absorption
Absorbed following nasal administration.
There is little information available on the mechanism of action of vomeropherins. These compounds are delivered to the nasal passages and bind to chemoreceptors that in turn affect the hypothalamus and the limbic system.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
22
PharmaCompass offers a list of Fasedienol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fasedienol manufacturer or Fasedienol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fasedienol manufacturer or Fasedienol supplier.
PharmaCompass also assists you with knowing the Fasedienol API Price utilized in the formulation of products. Fasedienol API Price is not always fixed or binding as the Fasedienol Price is obtained through a variety of data sources. The Fasedienol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Aloradine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aloradine, including repackagers and relabelers. The FDA regulates Aloradine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aloradine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aloradine supplier is an individual or a company that provides Aloradine active pharmaceutical ingredient (API) or Aloradine finished formulations upon request. The Aloradine suppliers may include Aloradine API manufacturers, exporters, distributors and traders.
Aloradine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aloradine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aloradine GMP manufacturer or Aloradine GMP API supplier for your needs.
A Aloradine CoA (Certificate of Analysis) is a formal document that attests to Aloradine's compliance with Aloradine specifications and serves as a tool for batch-level quality control.
Aloradine CoA mostly includes findings from lab analyses of a specific batch. For each Aloradine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aloradine may be tested according to a variety of international standards, such as European Pharmacopoeia (Aloradine EP), Aloradine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aloradine USP).
